摘要
虽然腺相关病毒载体的研究由来已久,但是其作为一种重要可行的基因治疗策略已被推到注意中心只在最近几年。由于这些载体的优良特性,它们的潜力已精心利用在多种神经系统疾病的治疗。本文在扼要介绍的腺相关病毒载体治疗进展的治疗帕金森病的研究各种动物模型实验和临床试验针对基因治疗的腺相关病毒载体的出现。此外,在审查研究的年代学分析使得它更容易理解的挑战和预言未来的前景在这一领域的治疗药物。
关键词: 腺相关病毒,腺相关病毒,帕金森氏病的基因治疗。
Current Gene Therapy
Title:Therapeutic Value of Adeno Associated Virus as a Gene Therapy Vector for Parkinson's Disease – A Focused Review
Volume: 16 Issue: 4
Author(s): Aastha Singh, Dwaipayan Sen
Affiliation:
关键词: 腺相关病毒,腺相关病毒,帕金森氏病的基因治疗。
摘要: Although adeno-associated viral vectors have been studied for a long time, its importance as a viable gene therapy strategy has been thrusted into the limelight only in the recent years. Due to the admirable characteristics of these vectors, their potential has been thoughtfully utilized in the treatment of several neurodegenerative diseases. This mini-review focuses at recapitulating the therapeutic advances of adeno-associated viral vectors in the treatment of Parkinson’s disease by studying the various animal model experiments and clinical trials conducted since the advent of adeno-associated viral vector - based gene therapy. Additionally, the chronological analysis of the studies in the review makes it easier to understand the challenges and foretell the future prospects in this field of therapeutics.
Export Options
About this article
Cite this article as:
Aastha Singh, Dwaipayan Sen , Therapeutic Value of Adeno Associated Virus as a Gene Therapy Vector for Parkinson's Disease – A Focused Review, Current Gene Therapy 2016; 16 (4) . https://dx.doi.org/10.2174/1566523216666160729113558
DOI https://dx.doi.org/10.2174/1566523216666160729113558 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Docking Study of Catecholamines and [4-(Propan-2-yl) Phenyl]Carbamic acid with Tyrosine Hydroxylase
CNS & Neurological Disorders - Drug Targets Nasal Polyposis: An Overview of Differential Diagnosis and Treatment
Recent Patents on Inflammation & Allergy Drug Discovery Homology Modeling of Adenosine A2A Receptor and Molecular Docking for Exploration of Appropriate Potent Antagonists for Treatment of Parkinsons Disease
Current Aging Science Pharmacogenetics of Parkinson’s Disease – Through Mechanisms of Drug Actions
Current Genomics Current Antioxidant Molecular Therapies for Oxidative Stress-Related Ailments
Current Gene Therapy Incomplete Coverage of Candidate Genes: A Poorly Considered Bias
Current Genomics Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
Current Neuropharmacology Oxidative Stress, Antioxidants and Neurodegenerative Diseases
Current Pharmaceutical Design Nutraceuticals against Neurodegeneration: A Mechanistic Insight
Current Neuropharmacology Synthesis of 3-(2-chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2- a] pyrimidin-4-one Derivatives as Antibacterial Agents
Medicinal Chemistry Cannabinoids for the Treatment of Schizophrenia: An Overview
Current Topics in Medicinal Chemistry An Update on GABA Analogs for CNS Drug Discovery
Recent Patents on CNS Drug Discovery (Discontinued) Peak Treadmill Exercise Echocardiography
Reviews on Recent Clinical Trials Novel Technologies for Dipeptide Drugs Design and their Implantation
Current Pharmaceutical Design The Therapeutic Potential of Melatonin in Neurological Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Serum Vitamin E (α-Tocopherol) Estimation: A Potential Biomarker of Antioxidant Status Evaluation on Heavy Metal Toxicities
Recent Patents on Biomarkers Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Clinical Implications of CYP2D6 Genetic Polymorphism During Treatment with Antipsychotic Drugs
Current Drug Targets Deciphering the Role of Nanoparticle-based Treatment for Parkinson’s Disease
Current Drug Metabolism Metabotropic Glutamate Receptors in Central Nervous System Diseases
Current Drug Targets